All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

Computational Design of Peptide Masks Enables Conditionally Active Miniprotein Therapeutics

By

Benjamí Oller-Salvia

2d ago· 36 min readenNews

Summary

This article presents a novel computational approach for designing conditionally active miniprotein binders through de novo peptide masks. The method addresses a key challenge in protein therapeutics: targets are often expressed in both diseased and healthy tissues, causing dose-limiting toxicities. The researchers engineered peptide masks that block the binding interface of miniproteins until they are cleaved by disease-associated proteases, enabling site-specific activation. The paper details the computational design pipeline, experimental validation, and demonstrates successful application across multiple therapeutic targets. This represents a significant advance in creating safer, more targeted protein therapeutics with improved therapeutic indices.

Source

Twitter / XComputational Design of Peptide Masks Enables Conditionally Active Miniprotein Therapeuticspubs.acs.org

Key quotes

· 3 pulled
Protein therapeutics have transformed the treatment of diseases ranging from cancer to immune disorders, largely owing to their high target selectivity.
Yet many therapeutic targets are expressed not only at diseased sites but also in healthy tissues, frequently leading to dose-limiting toxicities.
A compelling strategy to improve the therapeutic index is to engineer conditionally active biologics that remain inert systemically and are activated only at the site of disease.
Snippet from the RSS feed
The widespread expression of therapeutic targets in both diseased and healthy tissues poses a major challenge for protein-based therapeutics, often leading to dose-limiting side effects. One promis...

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.